Cargando…

Molecular and serological characterization of hepatitis B vaccine breakthrough infections in serial samples from two plasma donors

BACKGROUND: Although vaccines for hepatitis B virus (HBV) are highly effective, HBV infections in vaccinees occur. Index samples of breakthrough infections are typically anti-HBc negative but HBV DNA positive with protective anti-HBs levels while HBsAg detection may be delayed or absent. HBsAg mutat...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kuhns, Mary C., McNamara, Anne L., Holzmayer, Vera, Cloherty, Gavin A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2019
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6448254/ https://www.ncbi.nlm.nih.gov/pubmed/30943997 http://dx.doi.org/10.1186/s12985-019-1154-4

Ejemplares similares

Molecular and Serological Characterization of Hepatitis B Virus (HBV)-Positive Samples with Very Low or Undetectable Levels of HBV Surface Antigen
por: Kuhns, Mary C., et al.
Publicado: (2021)

Hepatitis B seroconversion revisited: new insights into the natural history of acute hepatitis B virus (HBV) infection from quantitative and highly sensitive assays and novel biomarkers
por: Kuhns, Mary C., et al.
Publicado: (2021)

Evaluation of hepatitis C virus antibody assay using dried blood spot samples
por: Holzmayer, Vera, et al.
Publicado: (2022)

Identification of hepatitis B virus genotype I in Thailand
por: Holzmayer, Vera, et al.
Publicado: (2018)

Expanding access to SARS-CoV-2 IgG and IgM serologic testing using fingerstick whole blood, plasma, and rapid lateral flow assays
por: Anderson, Mark, et al.
Publicado: (2021)

Development and performance of prototype serologic and molecular tests for hepatitis delta infection
por: Coller, Kelly E., et al.
Publicado: (2018)

Author Correction: Development and performance of prototype serologic and molecular tests for hepatitis delta infection
por: Coller, Kelly E., et al.
Publicado: (2020)

Persistent Control of Hepatitis B Virus and Hepatitis Delta Virus Infection Following REP 2139‐Ca and Pegylated Interferon Therapy in Chronic Hepatitis B Virus/Hepatitis Delta Virus Coinfection
por: Bazinet, Michel, et al.
Publicado: (2020)

More DNA and RNA of HBV SP1 splice variants are detected in genotypes B and C at low viral replication
por: Luk, Ka-Cheung, et al.
Publicado: (2021)

Cryptic HBV Replicative Activity Is Frequently Revealed in Anti-HBc-Positive/HBsAg-Negative Patients with HIV Infection by Highly Sensitive Molecular Assays, and Can Be Predicted by Integrating Classical and Novel Serological HBV Markers
por: Salpini, Romina, et al.
Publicado: (2020)

Hepatitis C RNA assay differences in results: Potential implications for shortened therapy and determination of Sustained Virologic Response
por: Cloherty, Gavin, et al.
Publicado: (2016)

Role of Serologic and Molecular Diagnostic Assays in Identification and Management of Hepatitis C Virus Infection
por: Cloherty, Gavin, et al.
Publicado: (2016)

Hepatitis B genotypes and surface antigen mutants present in Pakistani blood donors
por: Harris, Barbara J., et al.
Publicado: (2017)

Serological and molecular characterization of hepatitis B virus in asymptomatic blood donors in Iran
por: Attaran, Mona Seyed, et al.
Publicado: (2018)

Analysis of HBsAg Immunocomplexes and cccDNA Activity During and Persisting After NAP‐Based Therapy
por: Bazinet, Michel, et al.
Publicado: (2021)

HBsAg isoform dynamics during NAP‐based therapy of HBeAg‐negative chronic HBV and HBV/HDV infection
por: Bazinet, Michel, et al.
Publicado: (2022)

Serological response and breakthrough infection after COVID-19 vaccination in patients with cirrhosis and post-liver transplant
por: Mehta, Gautam, et al.
Publicado: (2023)

Hepatitis C virus surveillance and identification of human pegivirus 2 in a large Cameroonian cohort
por: Rodgers, Mary A., et al.
Publicado: (2018)

Molecular and serological characterization of occult hepatitis B among blood donors in Maputo, Mozambique
por: Mabunda, Nédio, et al.
Publicado: (2020)

SARS-CoV-2 serology and virology trends in donors and recipients of convalescent plasma
por: Dulipsingh, Latha, et al.
Publicado: (2020)

Serological Patterns and Molecular Characterization of Occult Hepatitis B Virus Infection among Blood Donors
por: Lin, Hong, et al.
Publicado: (2016)

Hepatitis B serological markers and plasma DNA concentrations
por: Price, Huw, et al.
Publicado: (2017)

The demographic and serological characteristics of COVID-19 convalescent plasma donors: Identification of basic criteria for optimal donor selection
por: Fazeli, Alieh, et al.
Publicado: (2022)

Highly Sensitive HBsAg, Anti-HBc and Anti HBsAg Titres in Early Diagnosis of HBV Reactivation in Anti-HBc-Positive Onco-Haematological Patients
por: Cerva, Carlotta, et al.
Publicado: (2022)

ARCHITECT HIV Combo Ag/Ab and RealTime HIV-1 Assays Detect Diverse HIV Strains in Clinical Specimens
por: Rodgers, Mary A., et al.
Publicado: (2018)

Urticaria after breakthrough Omicron BA.5.1 severe acute respiratory syndrome coronavirus 2 infection in a triple-vaccinated (Pfizer) patient: a case report
por: Ciuoderis, Karl, et al.
Publicado: (2023)

Virological and serological kinetics of SARS-CoV-2 Delta variant vaccine breakthrough infections: a multicentre cohort study
por: Chia, Po Ying, et al.
Publicado: (2022)

Enhancement of the Molecular and Serological Assessment of Hepatitis E Virus in Milk Samples
por: Sayed, Ibrahim M., et al.
Publicado: (2020)

Identifying immunity gaps for measles using Belgian serial serology data
por: Schenk, Julie, et al.
Publicado: (2022)

Utility of the Cobas(®) Plasma Separation Card as a Sample Collection Device for Serological and Virological Diagnosis of Hepatitis C Virus Infection
por: Velásquez-Orozco, Fernando, et al.
Publicado: (2021)

Breakthroughs and challenges in the management of pediatric viral hepatitis
por: Nicastro, Emanuele, et al.
Publicado: (2021)

Vaccines in Breast Cancer: Challenges and Breakthroughs
por: Fatima, Gul Naz, et al.
Publicado: (2023)

Prophylactic Hepatitis E Vaccines: Antigenic Analysis and Serological Evaluation
por: Li, Yike, et al.
Publicado: (2020)

Booster vaccines for COVID-19 vaccine breakthrough cases?
por: Nixon, Douglas F, et al.
Publicado: (2022)

Dried Blood Spot Sampling for Hepatitis B Virus Serology and Molecular Testing
por: Mohamed, Sofiane, et al.
Publicado: (2013)

Sensitivity and specificity of parallel or serial serological testing for detection of canine Leishmania infection
por: de Arruda, Mauro Maciel, et al.
Publicado: (2016)

Breakthroughs in hepatitis C research: from discovery to cure
por: Manns, Michael P., et al.
Publicado: (2022)

Detection of SARS-CoV-2 antibodies after confirmed Omicron BA.1 and presumed BA.4/5 infections using Abbott ARCHITECT and Panbio assays
por: Boler, Michael, et al.
Publicado: (2023)

569. Characterization of COVID-19 Vaccine Breakthrough Infections in Metropolitan Detroit
por: sturla, Nicholas, et al.
Publicado: (2021)

Factors affecting the serological testing of cadaveric donor cornea
por: Raj, Anuradha, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_rf2e0ic9unc4akd77bkntmf7ld